Abstract. During bone resorption, osteoclasts form a tight attachment, the sealing zone, around resorption lacunae. Vitronectin receptor has previously been shown to be expressed in osteoclasts and it has been suggested that it mediates the tight attachment at the sealing zone. In this study we have shown that glycinearginine-glycine-aspartic acid-serine pentapeptide inhibits bone resorption by isolated osteoclasts and drastically changes the morphology of the osteoclasts . When the vitronectin receptor was localized by immunofluorescence in rat and chicken osteoclasts cultured on bone slices, it was found to be distributed throughout the osteoclast cell membrane except in the sealing zone areas. Immunoperoxidase staining of rat bone sections at the light microscopical level also revealed in-0 TEOC1.ASTs are multinucleated cells responsible for bone resorption . When actively resorbing they are polarized and have three specialized cell membrane areas. Resorption of bone takes place in the ruffled border area, where protons and proteases are secreted into the resorption lacuna between the ruffled border membrane of the osteoclast and the bone surface (Baron et al., 1988 ; Blair et al ., 1989; Bekker and Gay, 1990; Sundquist et al ., 1990; . The ruffled border area is surrounded by a sealing zone, which forms a tight attachment ofthe cell membrane to the underlying bone surface, thereby isolating the resorption lacuna from the extracellular fluid and permitting the maintenance of a cell-generated pH gradient. Previously we have described the formation of a specific microfilament organization around resorption lacunae in resorbing osteoclasts (Lakkakorpi et al., 1989 ). Recently we have further characterized the kinetics of this microfilament structure and demonstrated its stepwise formation into the sealing zone area (Lakkakorpi and Vaananen, 1991) . The third specialized membrane domain of the active osteoclast, the basolateral membrane, faces the bone marrow and is not in contact with the mineralized bone matrix .
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The molecular mechanisms by which osteoclasts attach to the bone surface are not well understood. The vitronectin receptor (a,a3), one member of the integrin superfamily (Hynes, 1987) , has been shown to be expressed in os- subunits of the vitronectin receptor were similarly localized . These results strongly suggest that, although the vitronectin receptor is important in the function of osteoclasts, it is not mediating the final sealing zone attachment of the osteoclasts to the mineralized bone surface .
teoclasts Horton, 1990; Helfrich et al ., 1992) . Bone resorption by human and chick osteoclasts can be inhibited with antibodies against the vitronectin receptor (Chambers et al., 1986; Horton et al., 1991) . Recently it has been suggested that the vitronectin receptor mediates the tight attachment of osteoclasts to bone matrix (Reinholt et al., 1990; Sato et al., 1990) , and that osteopontin is the ligand of the osteoclast vitronectin receptor (Reinholt et al., 1990) .
Ligand binding of 03 integrins is mediated via an arginine-glycine-aspartic acid (RGD)' peptide sequence within their ligands (Ruoslahti and Pierschbacher, 1986; Hynes, 1987; Ruoslahti and Pierschbacher, 1987) . Recently Sato et al. (1990) showed that echistatin, a protein purified from the venom of the saw-scaled viper Echis carinatus and containing an RGD sequence, inhibits bone resorption. They also tentatively identified the echistatin receptor in osteoclasts as the vitronectin receptor. In this study we have examined the effects of synthetic peptides with and without an RGD sequence on resorption activ-ity and morphology of osteoclasts in vitro . We have also used several mono-and polyclonal antibodies, which recognize different domains of vitronectin receptor, to localize this receptor on osteoclasts at both the light and electron microscopic levels .
A preliminary report of these experiments with the syn- Procedures for the culture of ostecelasts on bone slices were slightly modified from the original methods of Boyde et al . (1984) and Chambers et al . (1984) and have been described previously in detail (I.akkakorpi et al ., 1989 ; Lakkakorpi and Viiänänen, 1990) . Briefly, ostecelasts that had been mechanically harvested from long bones of 3-4-d-old rat pups or 3-6-d-old chicks bY curetting the endosteal surface with a scalpel blade were allowed to attach to transverse slices (100-150 Wm thick) of bovine cortical bone. After 30 min (rat) or 100 min (chicken) nonattached cells were washed away and the cells on bone slices were cultured in DME buffered with 20 mM HEPES and containing 0.84 g/liter sodium bicarbonate, 2 mM t-glutamine, 100 IU/ml penicillin, 100~cg/ml streptomycin, and 109'°heat-inactivated FCS, pH 6.9, at 37°C and 596 C02/95% air for 1 d. Studied peptides were added to the medium after cells were allowed to attach to bone slices . To determine thé resorption activity, bone slices were fixed with 3 paraformaldehyde and 296 sucrose in PBS, pH 7.1, for 5 min and stained with i% toluidine blue in 1% sodium borate . Bone slices were screened with a 25x objective to count multinucleated ostecelasts. The cells were then removed by ultrasonication in 0.25 M ammonium hydroxide and the resorption pits were counted with phase contrast optics. The resorption index for each bone slice was assessed as the number of resorption pits per osteoclast number . For comparison of data from different experiments, the resorption index of control was used as 100% .
We have shown earlier that the multinucleated cells in these cultures are osteoclasts since they express tartrate-resistant acid phosphatase, actively resorb bone during the culture period, and respond to calcitonin with rapid cytoplasmic retraction and changes in microfilament organization (Lakkakorpi et al ., 1989 ; Lakkakorpi and Väänänen, 1990 ) .
Synthetic Peptides
Pentapeptide glycine-arginine-glycine-aspartic acid-serine (GRGDS) and tripeptide RGD were purchased from Sigma Chemical Co . (St . Louis, MO) . Pentapeptide glycine-arginine-glycine-glutamic acid-serine (GRGES) was synthetized with an automated synthesizer (model 430A ; Applied Biosystems, Inc., Foster City, CA) using t-Boc chemistry and purified preparatively using HPLC, and the composition was verified by amino acid sequencing at the Department of Biochemistry, University of Oulu (Oulu, Finland) .
Antibodies
Several mono-and polyclonal antibodies against the vitronectin receptor, a~ßs, were used to localize the receptor at both light and electron microscopic levels. The rabbit polyclonal ântibody purchased from Telios Pharmaceuticals, Inc . (San Diego, CA) recognizes both the a~and ßs (and possibly ßs) subunits of the entire vitronectin receptor complex and was used at 1:50 dilution (anti VNR) . Polyclonal anti-ßs and anti-a~were a kind gift of Dr. E . Ruoslahti (Cancer Research Center, La Jolla, CA) . The anti-ßs antiserum was raised against a synthetic peptide encompassing the entire cytoplasmic domain of the ßs chain and the anti-a~antiserum against an intracellular COOH-terminal fragment of a~chain (Freed et al ., 1989) . They were both used at 1 :50 and 1:100 dilutions . Polyclonal RBI antibody (Nesbitt et al ., 1989) , 1992) and were used as tissue culture supernatants. Monoclonal antibody 23C6 (Horton et al ., 1985) recognizes the intact aß3 complex of the vitronectin receptor and was also used as neat tissue culture supernatant . Rhodamine-conjugated rabbit anti-mouse, rhodamine-conjugated swine anti-rabbit, swine anti-rabbit, and rabbit anti-mouse Ig were purchased from DAKOPATTS A/S (Glostrup, Denmark) and used at 1:50, 1 :20, 1 :20, and 1 :20 (for peroxidase stainings) or 1 :100/1 :150 (for immuncelectron microscopic [IEM]) dilutions, respectively. Rabbit and mouse peroxidaseantiperoxidase complex were also purchased from DAKOPATTS A/S . 10-nm protein A-gold complexes were a gift from Dr. Raija Sormunen (Department of Pathology, University of Oulu, Oulu, Finland), and were prepared according to Slot and Geuze (1985) .
Immunoperoxidase and Immunolluorescence Stainings
Paraffin sections from Carnoy fixed 17-d-old rat bone were stained by the peroxidase-antiperoxidase technique (Sternberger, 1979) . Sections were treated first with 1% BSA in PBS for 5 min and then with 1096 swine serum (for polyclonal primary antibodies) or 10% rabbit serum (for monoclonal primary antibodies) in PBS for 60 min . Sections were then incubated with the primary antibody overnight at 4°C, washed for 30 min in PBS, and incubated with swine anti-rabbit Ig diluted 1 :20 in 10% swine serum in PBS (for polyclonal primary antibodies) or with rabbit anti-mouse Ig diluted 1 :20 in 1096 rabbit serum in PBS (for monoclonal primary antibodies) for 30 min . After a 30-min wash with constant stirring in PBS, sections were incubated with rabbit or mouse peroxidase-antiperoxidase complex diluted 1 :100 in PBS for 30 min. After a further 30-min wash in PBS the peroxidase reaction was performed with H202 and diaminobenzidine for 5 min . Finally, sections were washed with deionized water and mounted in glycerol .
For immunofluorescense microscopy, ostecelasts cultured on bone slices were rinsed with PBS, fixed with 3 % paraformaldehyde and 2 % sucrose in PBS for 5 min at room temperature, rinsed in PBS, permeabilized in HepesTriton X-100 buffer (20 mM Hepes, pH 7.0, 300 mM sucrose, 50 mM NaCI, 3 mM MgC12, and 0.596 Triton X-100) for 5 min at 0°C, and finally rinsed in PBS . Bone slices were incubated with primary antibodies for 1 h at 37°C, thoroughly rinsed in PBS, and then incubated in a rhodamine-conjugated secondary antibody for 30 min at 37°C. Before addition of polyclonal primary antibodies, bone slices were incubated with 10% swine serum for 30 min at 37°C ; 10% swine serum was also added to the secondary antibody solution . F-actin was stained with 5 U/ml rhodaminelabeled phalloidin (Molecular Probes, Inc ., Eugene, OR) .
Immunoelectron Microscopy 5-d-old rat pups were killed by decapitation, the distal femurs were quickly dissected out, and slices were cut from the primary spongiosa area under the growth plate at 0°C . Slices were immersed in 2% fresh paraformaldehyde and 0.2 % glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for 3 h . Ultracryotomy was performed according to Tokuyasu (1973) with minor modifications . Thin sections of N100 nm were prepared on a Nova ultracryotome equipped with a diamond knife (LKB Instruments, Inc., Gaithersburg, MD) . The protein A-gold technique (Geuze et al ., 1991) was used to localize the vitronectin receptor. After incubation in fluid gelatin at 37°C, grids were washed in PBS containing 0.02 M glycine, incubated with 1% NaBH4 for 10 min, washed in PBS, and further incubated with 
Results
GRGDS pentapeptide inhibited bone resorption by isolated rat osteoclasts in a dose-dependent manner over the range 10-3 -10 -a M when measured by counting the number of resorption pits per osteoclast (Fig. 1) . At a concentration of 1 mM, total inhibition of bone resorption was achieved with an IC50 of -0.1 jAM . The number of osteoclasts was significantly reduced in the presence of 0.1 and 1 mM GRGDS peptide . The pentapeptide with aspartic acid replaced by glutamic acid (GRGES) and the tripeptide, RGD, had no significant effect on osteoclast resorption activity (Fig . 1) . However, at a high concentration (0.1 mM) of GRGES, the number of osteoclasts adhering to the bone slices was significantly reduced .
GRGDS pentapeptide concentrations of 0.01 mM or more caused clearly visible changes in the shape of rat osteoclasts (Figs . 2 and 3 ) . Osteoclasts were retracted from the bone surface and had long rigid extensions . A concomitant disappearance of the specific microfilament organization at the attachment areas was revealed by actin staining (Fig . 3) .
Since the vitronectin receptor is expressed in osteoclasts, it is possible that the interaction of GRGDS peptide with the vitronectin receptor caused the observed changes in osteoclast behavior. To localize vitronectin receptor in osteoclasts we used several antibodies that recognize the a, or 03 chain or the whole vitronectin receptor complex . With peroxidase staining of rat bone sections we observed an intense reaction at the cell membrane of osteoclasts with occasional small unstained areas probably corresponding to sealing zones (Fig. 4) . This staining of osteoclast cell membranes in paraffin sections was observed with antiVNR, polyclonal anti-N3, and RBI (anti-a,.) antibodies.
Immunofluorescence staining of cultured rat and chicken osteoclasts was performed with all the antibodies listed with similar results . We observed specific staining all over the osteoclast plasma membrane ; in resorbing osteoclasts the ruffled border areas over resorption lacunae were most intensively stained . The weakest staining was found around the resorption pits (Fig . 5) . In no case was there evidence of increased accumulation of vitronectin receptor around the edges of the resorption pits.
The results obtained at the light microscopic level suggested that the vitronectin receptor in osteoclasts is not polarized to the sealing zone areas, and this finding was confirmed by IEM of rat bone sections . The IEM was carried out with antiVNR and monoclonal Fl l antibodies with similar results . Most of the immunoreaction was at the baso- lateral membrane (Fig. 6, a and d) ; the ruffled border was also clearly stained (Fig. 6 b) . At the sealing zone we could not find any indication of specific staining (Fig. 6 c) . In bone matrix there was some nonspecific staining, but otherwise the controls showed only minimal staining (Fig. 6 e) . The immunoreactivity was semiquantified with the antiVNR antibody (Table I ) . The highest density of gold particles (2.43 gold particles/pm of membrane) was found in the basolateral membrane, and the ruffled border membrane and sealing zone membrane showed only 34 and 2 % of that density, respectively. The frequency of gold particles at the sealing zone was at the same level in anti-VNR antibody-stained and control osteoclasts .
Discussion
In this study we describe the effects of different synthetic peptides on osteoclast behavior in vitro. The pentapeptide, GRGDS, inhibited bone resorption in a dose-dependent manner with an ICso of 0.1 AM. RGD tripeptide had no statistically significant effect on resorption activity at the concentration tested . It has been previously reported that the RGD tripeptide is inactive in inhibition of cell adhesion at the doses tested ; COOH-terminal amidation of the RGD tripeptide or addition of flanking amino acid sequences was required for activity against integrin receptors . Sato et al . (1990) , using a similar resorption assay with rat osteoclasts, have recently shown that the ICso of the tetrapeptide arginine-glycine-aspartic acid-serine (RGDS), is 100 AM and that of echistatin, 0.1 nM . These results, when taken with our data, clearly show that in addition to the presence of the RGD sequence, the correct conformation at the RGD peptide region is also important for maximal inhibitory activity. Moreover, substituLakkakorpi et al . Vitronectin Receptor in Osteoclasts Figure S . Immunofluorescence staining of cultured rat osteoclasts with monoclonal F4 antibody, which recognizes the extracellular domain of the 03 chain (a), and with polyclonal anti-N3 antibody, which recognizes the intracellular domain of the 03 chain (c), and ofchicken osteoclast with monoclonal antibody 23C6, which recognizes the a..03 vitronectin receptor complex (d) . The figure shows the normal light microscopic picture of corresponding resorption lacunae under the osteoclasts (b and e). There is intense staining at the ruffled border areas over resorption pits (a, c, and d, asterisks) and there are dark areas with very faint staining at the sealing zone areas (a and d, arrows) around the resorption pits (b and e) . In the nonresorbing, probably migrating, osteoclast (c, large arrow) there is a faint staining all over the cell membrane. Bars, 20 Am (a and b) and 10 Am (c-e) .
tion of one amino acid in the RGD sequence causes the loss of the inhibitory effect, since pentapeptide GRGES does not inhibit bone resorption . A similar result was obtained with echistatin by changing the arginine to alanine in its RGD sequence (Sato et al ., 1990) .
GRGDS concentrations of 0 .1 mM or more caused clear changes in osteoclast morphology. Our data agree with the earlier findings that higher peptide concentrations are needed for visible morphological changes than for the inhibition of resorption (Sato et al., 1990) . Retraction of osteoclasts probably leads in some cases to cellular detachment from bone surface, thus explaining the reduction of the number of osteoclasts with high concentrations of GRGDS peptide . The number of osteoclasts was also reduced in the presence of 0.1 mM GRGES peptide without any specific effect on resorption activity. The explanation for this phenomenon is unclear, though in a separate study (Horton et al., 1991) high doses (400 ELM) of a slightly different peptide, glycine-arginine-glycine-glutamic acid-serine-proline (GRGESP), reduced osteoclastic resorption . Similar findings have been reported in other cell systems involving differentintegrin receptors . Arginine-glycine-glutamic acid (RGE) peptides are, in fact, weak antagonists (1,000-fold less active) when assayed in solid phase receptor assays for fibronectin receptor (Hautanen et al ., 1989) . They are generally ineffective in cell binding assays , although inhibitory activity has been reported in some cell systems involving collagen and other integrin receptors (Grinell et al., 1989 ; Lawrence et al., 1990) .
Because of the restricted expression of al integrins in osteoclasts, by immunocytochemical techniques only evidence for expression of the RGDindependent collagen/laminin receptor «2161 (Wayner et al., 1988; Elices and Hemler, 1989) was found . The receptor for the RGD-containing peptides on osteoclasts is probably the vitronectin receptor, which does require an RGD sequence to bind its ligand (Pytela et al ., 1985) . When we localized the vitronectin receptor in osteoclasts with several antibodies at both light and electron microscopic levels intense cell membrane staining was observed with all the techniques used. Semiquantitation of the immunoreactivity in IEM showed that all specific staining was either at the basolateral membrane or at the ruffled border (2 .43 and 0.82 gold particles/gm of membrane, respectively) . The level of the staining at the sealing zone was similar in antibody-stained and control sections (0.05 and 0.06 gold particles/Am of membrane, respectively) . This, together with our immunofluorescence data, strongly argues against a proposed hypothesis that the tight attachment of osteoclast sealing zone membrane to bone matrix is mediated by the vitronectin receptor (Reinholt et al., 1990) . Staining with antibodies against ce, and ,Q3 chains gave similar results, suggesting that both vitronectin receptor subunits are coexpressed, and colocalized, in osteoclasts. The extensive convolutions of the cell membrane in the ruffled border intensified the staining at the Lakkakorpi et al. Vitronectin Receptor in Osteoctasts 1185 light microscopic level and thus the brighter staining was seen over resorption lacunae when the immunofluorescence staining method was used. It is possible that ligand occupancy of the vitronectin receptor might prevent the binding ofantibodies to the extracellular domain ofthe receptor ; because of this possibility we also used antibodies that recognize the intracellular domain of the a v and 03 subunits that would be unaffected by ligand binding. Theseantibodies gave results similar to the others, strengthening the suggestion that the vitronectin receptor is lacking at the sealing zone membrane . Antibody 23C6, which recognizes the a ..,Q3 vitronectin receptor complex in chicken osteoclasts, also gave similar results, indicating that the observed distribution ofvitronectin receptor is not restricted to rat osteoclasts .
These data, as well as the results of others (Chambers et al ., 1986; Horton et al., 1991) , indicate that vitronectin receptor has an important functional role in bone resorption. However, in contrast to some earlier studies (Reinholt et al., 1990) , we could not demonstrate vitronectin receptor at the sealing zone membrane, suggesting that tight attachment of osteoclasts to bone surface is not mediated by this integrin . The colocalization of vitronectin receptor and vinculin in podosome-like structures described by Zambonin-Zallone et al. (1989) may indicate its role in the attachment of resting and migrating osteoclasts to bone surface. The fact that we could not detect the vitronectin receptor at the sealing zone membrane is in agreement with our earlier findings that the association of actin and vinculin seen in podosomes is clearly different in the sealing zone area (Lakkakorpi et al., 1989; Lakkakorpi and Vaananen, 1991) . Vinculin is also lacking from the most central area of the sealing zone, indicating that some organization other than a high density of podosomes mediates the attachment ofresorbing osteoclasts to bone surface. Thus the exact nature of the molecular mechanism responsible for the formation oftight attachment between the bone surface and the sealing zone membrane of the resorbing osteoclasts remains unclear. Whether this relates to the exclusion of the vitronectin receptor from the membrane to allow close apposition of membrane to bone, forming an ion-impermeable seal, or to the involvement of a further class of receptors remains to be established. By analogy with other cell types (Springer, 1990) , adhesion of osteoclasts, their migration over the bone surface, and their formation of a tight sealing zone may be processes that are controlled by different classes of receptors interacting with their ligands over different distances between cell and matrix .
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